Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa (EASE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03068780
Recruitment Status : Recruiting
First Posted : March 3, 2017
Last Update Posted : January 28, 2020
Information provided by (Responsible Party):
Amryt Pharma ( Amryt Research Limited )

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2020
Estimated Study Completion Date : February 2022